Particle Counting in Injectable Solutions - Applications Note
This paper discusses the requirements laid out by US (USP), European (EP), and Japanese (JP) Pharmacopoeia standards and includes the most recent USP <788> (USP 42 2018), EP 5.1 and JP 17 release information. These standards demand that injectable solutions are effectively monitored for microcontamination, specifically nonsoluble particulates.
Most popular related searches
Stay in the loop!
Select your areas of interest to receive industry updates.